PRL and pituitary apoplexy: Consistent with these concepts, in our literature review, we found 43 cases of pituitary apoplexy associated with the use of DAs (cabergoline and bromocriptine), and the majority of them were PRL-secreting (90%) PitNETs, while the remaining PitNETs were secreting GH or TSH.